Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy.

Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, Wang W, Yerebakan C, Li W, Gaebel R, Li RK, Vollmar B, Steinhoff G, Ma N.

Microvasc Res. 2009 May;77(3):370-6. doi: 10.1016/j.mvr.2009.02.001.

PMID:
19249320
2.

Intra-articular Injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect.

Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, Murakami T, Kobayashi E.

Stem Cells. 2009 Apr;27(4):878-87. doi: 10.1634/stemcells.2008-0616.

3.

Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons.

Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR.

Cell Transplant. 2006;15(8-9):711-21.

PMID:
17269442
4.

Construction and characterization of fragmented mesenchymal-stem-cell sheets for intramuscular injection.

Chen CH, Chang Y, Wang CC, Huang CH, Huang CC, Yeh YC, Hwang SM, Sung HW.

Biomaterials. 2007 Nov;28(31):4643-51.

PMID:
17673287
5.

Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.

Song SW, Chang W, Song BW, Song H, Lim S, Kim HJ, Cha MJ, Choi E, Im SH, Chang BC, Chung N, Jang Y, Hwang KC.

Stem Cells. 2009 Jun;27(6):1358-65. doi: 10.1002/stem.47.

6.

Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors.

Xin H, Sun R, Kanehira M, Takahata T, Itoh J, Mizuguchi H, Saijo Y.

Mol Med. 2009 Sep-Oct;15(9-10):321-7. doi: 10.2119/molmed.2009.00059.

7.

Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice.

Toupet K, Maumus M, Peyrafitte JA, Bourin P, van Lent PL, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D.

Arthritis Rheum. 2013 Jul;65(7):1786-94. doi: 10.1002/art.37960.

8.

Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.

Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E.

Stem Cells Dev. 2011 Aug;20(8):1297-308. doi: 10.1089/scd.2010.0466.

PMID:
21303266
9.

Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction.

Ghanem A, Steingen C, Brenig F, Funcke F, Bai ZY, Hall C, Chin CT, Nickenig G, Bloch W, Tiemann K.

J Mol Cell Cardiol. 2009 Sep;47(3):411-8. doi: 10.1016/j.yjmcc.2009.06.008.

PMID:
19540842
10.

[Magnetic resonance imaging of mesenchymal stem cells transplanted intravascularly in treatment of acute renal failure:in vivo experiment with rats].

Sun JH, Teng GJ, Ma ZL, An YL, Mai XL, Ju SH, Yu H.

Zhonghua Yi Xue Za Zhi. 2008 Jul 15;88(27):1921-4. Chinese.

PMID:
19040008
11.

Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.

Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1606-16. doi: 10.1152/ajpheart.00590.2009.

12.
13.

Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice.

Galiè M, Konstantinidou G, Peroni D, Scambi I, Marchini C, Lisi V, Krampera M, Magnani P, Merigo F, Montani M, Boschi F, Marzola P, Orrù R, Farace P, Sbarbati A, Amici A.

Oncogene. 2008 Apr 17;27(18):2542-51.

PMID:
17998939
14.

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C.

Diabetologia. 2009 Jul;52(7):1391-9. doi: 10.1007/s00125-009-1374-z.

PMID:
19421731
15.

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Lee JW, Fang X, Gupta N, Serikov V, Matthay MA.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16357-62. doi: 10.1073/pnas.0907996106.

16.

Stem cell transplantation: the lung barrier.

Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP.

Transplant Proc. 2007 Mar;39(2):573-6.

PMID:
17362785
17.

Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells.

Rooney GE, McMahon SS, Ritter T, Garcia Y, Moran C, Madigan NN, Flügel A, Dockery P, O'Brien T, Howard L, Windebank AJ, Barry FP.

Tissue Eng Part A. 2009 Oct;15(10):3049-59. doi: 10.1089/ten.TEA.2009.0045.

PMID:
19335061
18.

Endovascular transplantation of stem cells to the injured rat CNS.

Lundberg J, Le Blanc K, Söderman M, Andersson T, Holmin S.

Neuroradiology. 2009 Oct;51(10):661-7. doi: 10.1007/s00234-009-0551-6.

PMID:
19562330
19.

Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.

Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K.

J Gene Med. 2009 May;11(5):373-81. doi: 10.1002/jgm.1313.

PMID:
19274675
20.

Mesenchymal stem cells: a good candidate for restenosis therapy?

Forte A, Galderisi U, Cipollaro M, Cascino A.

Curr Vasc Pharmacol. 2009 Jul;7(3):381-93. Review.

PMID:
19601863
Items per page

Supplemental Content

Support Center